Literature DB >> 34852174

The RNA-binding protein SRSF3 has an essential role in megakaryocyte maturation and platelet production.

Shen Y Heazlewood1,2, Tanveer Ahmad1,2, Monika Mohenska2, Belinda B Guo3, Pradnya Gangatirkar4, Emma C Josefsson4,5, Sarah L Ellis6,7, Madara Ratnadiwakara2,8,9, Huimin Cao1,2, Benjamin Cao1,2, Chad K Heazlewood1,2, Brenda Williams1,2, Madeline Fulton1,2, Jacinta F White1, Mirana Ramialison2, Susan K Nilsson1,2, Minna-Liisa Änkö2,8,9.   

Abstract

RNA processing is increasingly recognized as a critical control point in the regulation of different hematopoietic lineages including megakaryocytes responsible for the production of platelets. Platelets are anucleate cytoplasts that contain a rich repertoire of RNAs encoding proteins with essential platelet functions derived from the parent megakaryocyte. It is largely unknown how RNA binding proteins contribute to the development and functions of megakaryocytes and platelets. We show that serine-arginine-rich splicing factor 3 (SRSF3) is essential for megakaryocyte maturation and generation of functional platelets. Megakaryocyte-specific deletion of Srsf3 in mice led to macrothrombocytopenia characterized by megakaryocyte maturation arrest, dramatically reduced platelet counts, and abnormally large functionally compromised platelets. SRSF3 deficient megakaryocytes failed to reprogram their transcriptome during maturation and to load platelets with RNAs required for normal platelet function. SRSF3 depletion led to nuclear accumulation of megakaryocyte mRNAs, demonstrating that SRSF3 deploys similar RNA regulatory mechanisms in megakaryocytes as in other cell types. Our study further suggests that SRSF3 plays a role in sorting cytoplasmic megakaryocyte RNAs into platelets and demonstrates how SRSF3-mediated RNA processing forms a central part of megakaryocyte gene regulation. Understanding SRSF3 functions in megakaryocytes and platelets provides key insights into normal thrombopoiesis and platelet pathologies as SRSF3 RNA targets in megakaryocytes are associated with platelet diseases.
© 2022 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34852174      PMCID: PMC8900270          DOI: 10.1182/blood.2021013826

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  79 in total

1.  The splicing factors 9G8 and SRp20 transactivate splicing through different and specific enhancers.

Authors:  Y Cavaloc; C F Bourgeois; L Kister; J Stévenin
Journal:  RNA       Date:  1999-03       Impact factor: 4.942

2.  Global splicing pattern reversion during somatic cell reprogramming.

Authors:  Sho Ohta; Eisuke Nishida; Shinya Yamanaka; Takuya Yamamoto
Journal:  Cell Rep       Date:  2013-10-17       Impact factor: 9.423

3.  Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets.

Authors:  A S Weyrich; D A Dixon; R Pabla; M R Elstad; T M McIntyre; S M Prescott; G A Zimmerman
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

4.  The significance of megakaryocyte size.

Authors:  R F Levine; K C Hazzard; J D Lamberg
Journal:  Blood       Date:  1982-11       Impact factor: 22.113

5.  A dynamic intron retention program in the mammalian megakaryocyte and erythrocyte lineages.

Authors:  Christopher R Edwards; William Ritchie; Justin J-L Wong; Ulf Schmitz; Robert Middleton; Xiuli An; Narla Mohandas; John E J Rasko; Gerd A Blobel
Journal:  Blood       Date:  2016-03-09       Impact factor: 22.113

6.  An inducible lentiviral guide RNA platform enables the identification of tumor-essential genes and tumor-promoting mutations in vivo.

Authors:  Brandon J Aubrey; Gemma L Kelly; Andrew J Kueh; Margs S Brennan; Liam O'Connor; Liz Milla; Stephen Wilcox; Lin Tai; Andreas Strasser; Marco J Herold
Journal:  Cell Rep       Date:  2015-02-26       Impact factor: 9.423

7.  Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3.

Authors:  Mark K Larson; Steve P Watson
Journal:  Blood       Date:  2006-05-02       Impact factor: 22.113

Review 8.  SCL/TAL1: a multifaceted regulator from blood development to disease.

Authors:  Catherine Porcher; Hedia Chagraoui; Maiken S Kristiansen
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

9.  A GWAS sequence variant for platelet volume marks an alternative DNM3 promoter in megakaryocytes near a MEIS1 binding site.

Authors:  Sylvia T Nürnberg; Augusto Rendon; Peter A Smethurst; Dirk S Paul; Katrin Voss; Jonathan N Thon; Heather Lloyd-Jones; Jennifer G Sambrook; Marloes R Tijssen; Joseph E Italiano; Panos Deloukas; Berthold Gottgens; Nicole Soranzo; Willem H Ouwehand
Journal:  Blood       Date:  2012-09-12       Impact factor: 22.113

10.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2.

Authors:  Michael I Love; Wolfgang Huber; Simon Anders
Journal:  Genome Biol       Date:  2014       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.